AJMC January 1, 2025
Skylar Jeremias

Edgardo S. Santos, MD, FACP, FASCO, highlighted how liquid biopsies are transforming lung cancer care by enabling faster, less invasive diagnostics, with key applications in early detection, predictive biomarker identification, treatment response monitoring, resistance mechanism assessment, and minimal residual disease detection.

In an interview, Edgardo S. Santos, MD, FACP, FASCO, a hematologist and medical oncologist at the Oncology Institute of Hope and Innovation, highlighted how liquid biopsies are revolutionizing the early detection and management of lung cancer. He explained that liquid biopsies minimize the need for invasive procedures like surgical biopsies, which can lead to complications such as lung collapse. Additionally, the turnaround time for results has significantly improved, now taking just 3 to 5 days compared with 10 days...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, Provider, Trends
GenAI is already transforming the healthcare industry
Where Medicaid cuts stand
Q&A: Rural hospitals need help with cybersecurity survival
Radiology provider MedQuest part of deal to acquire 18 imaging centers from 1 of nation’s largest orthopedic groups
ASC block utilization by specialty

Share This Article